The global single-cell analysis market is projected to grow at an 18.1% CAGR during the forecast period (2016–2022). The growth of the market would be due to the increasing geriatric population, prevalence of cancer and infectious diseases, and healthcare expenditure. The technological advancements in the field and growing focus on personalized treatment are also furthering the growth of the market.
Insights on market segments
Consumables held the larger share of the single-cell analysis market in 2015 and are expected to grow at the faster pace during the forecast period as well, in terms of type of product. The category is further divided into assay kits, microplates, beads, reagents, and others. Out of these, reagents held the largest share of the market during the historical period (2012–2015).
On the basis of type of cell, the human cell category held the largest share of the single-cell analysis market in 2015, and it is predicted to grow at the fastest pace during the forecast period. This is attributed to the increasing investment on stem cell research and the growing prevalence of infectious diseases in the geriatric population.
On the basis of application, research dominated the single-cell analysis market during the historical period and is predicted to retain its position during the forecast period, owing to the availability of increased funds.
Hospitals are one of the major end-users in the single-cell analysis market. They are expected to dominate the market during the forecast period as they provide a safe environment and high-quality care to patients.
North America stands as the largest market for single-cell analysis
North America dominated the single-cell analysis market during the historical period and is predicted to retain its position during the forecast period. This would be due to the increasing healthcare expenditure, rising prevalence of chronic and infectious diseases, and improving healthcare infrastructure. The increasing geriatric population is another factor that is leading to the growth of the market in the continent.
Increasing healthcare expenditure leading to the growth of the market
Due to the growing prevalence of diseases and increasing government and non-government initiatives, the healthcare expenditure is rising as well. This, in turn, is leading to the increasing accessibility and affordability of medical diagnosis and treatment through single-cell analysis. Developed countries spend more on healthcare than developing countries. The increased expenditure in this field is leading to the growth in demand for single-cell analysis products, such as consumables and instruments, thereby furthering the progress of the single-cell analysis market.
Key companies are looking into mergers and acquisitions to grow
The key companies in the single-cell analysis market are looking into mergers and acquisitions to further their growth. For example, Thermo Fisher Scientific Inc. signed an agreement in March 2016 for the acquisition of Affymetrix Inc., a provider of cellular and genetic analysis products. This step was taken to strengthen the former company’s leadership in the genetic analysis and biosciences niche.
Among the key players operating in the global single-cell analysis market are Beckman Coulter Inc., Becton, Dickinson and Company, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, NanoString Technologies, Merck KGaA, Agilent Technologies Inc., and Fluidigm Corporation.
GLOBAL SINGLE-CELL ANALYSIS MARKET SEGMENTATION
By Type of Product
By Type Of Cell
By Type Of Technique
By Application
By End User
By Geography
